SCHEMBL22988904

SCHEMBL22988904

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4cc(-n5c6ccc7cccc8oc9cccc%10ccc5c(c%109)c6c78)ccc4c3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.39
ALDH1A1 P00352 3/20 0.39
KMT2A Q03164 3/20 0.39
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPK10 P53779 3/20 0.34
MAPK9 P45984 2/20 0.34
MAPT P10636 3/20 0.33
HPGD P15428 2/20 0.33
LMNA P02545 1/20 0.33
GLA P06280 1/20 0.33
UTRN P46939 1/20 0.32
NR3C1 P04150 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
TERT O14746 1/20 0.31
PGR P06401 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22988910 0.99 ALDH1A1 (0.41) MEN1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL22988912 0.96 KDM4E (0.36) MEN1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL22989258 0.96 MEN1 (0.38) MEN1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL22988958 0.92 L3MBTL1 (0.34) MEN1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL22988905 0.90 TERT (0.33) MEN1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL16284620 0.88 KMT2A (0.40) MEN1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL22988913 0.88 KDM4E (0.32) MEN1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL16284607 0.87 KMT2A (0.39) MEN1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL22988908 0.87 RPA1 (0.32) MEN1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL22989029 0.87 ATM (0.43) MEN1ALDH1A1KMT2ATP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021029757-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2021-02-18 WO disclosed
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 AUSPEX PHARMACEUTICALS, INC. 2016-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 JAK2, JAK3, PAK3 MEN1 4552/4885ALDH1A1 1603/4885KMT2A 1262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.